ACRS·00461U105·US·equity·Healthcare - Biotechnology-13D/G
ACRS (ACLARIS THERAPEUTICS INC) is held by 84 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($27.8M), RA CAPITAL MANAGEMENT, L.P. ($25.5M), ADAGE CAPITAL PARTNERS GP, L.L.C. ($14.5M). Net institutional sentiment: Mixed.
See how ACRS's score breaks down across 4 SEC sources
Showing 1-20 of 92
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer